Pharma: Other News To Note
• Mylan Inc. said its subsidiary Mylan Pharmaceuticals, of Pittsburgh, received FDA approval of its abbreviated new drug application (ANDA) for lithium carbonate extended-release tablets USP, 450 mg, to treat manic episodes of manic depressive illness. The FDA also approved Mylan's ANDA for a generic version of Provigil (modafinil, Cephalon Inc.).
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter